Patents by Inventor Andreas Luegering

Andreas Luegering has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tripeptide KDPT for antiapoptotic treatment
    Patent number: 9156881
    Abstract: The present invention is related to the tripeptide (I)Lys-(d)Pro-(I)Thr (KdPT) or pharmaceutically acceptable salts thereof for therapeutic, prophylactic therapeutic or cosmetic treatment of a disease with increased apoptosis, wherein the treatment has an anti-apoptotic effect. The present invention is also related to the use of KdPT or pharmaceutically acceptable salts thereof for the manufacture of a pharmaceutical or cosmetic composition for an anti-apoptotic treatment of disorders that are related with increased apoptosis.
    Type: Grant
    Filed: September 24, 2012
    Date of Patent: October 13, 2015
    Assignee: WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
    Inventors: Dominik Bettenworth, Markus Boehm, Andreas Luegering
  • TRIPEPTIDE KDPT FOR ANTIAPOPTOTIC TREATMENT
    Publication number: 20140323394
    Abstract: The present invention is related to the tripeptide (I)Lys-(d)Pro-(I)Thr (KdPT) or pharmaceutically acceptable salts thereof for therapeutic, prophylactic therapeutic or cosmetic treatment of a disease with increased apoptosis, wherein the treatment has an anti-apoptotic effect. The present invention is also related to the use of KdPT or pharmaceutically acceptable salts thereof for the manufacture of a pharmaceutical or cosmetic composition for an anti-apoptotic treatment of disorders that are related with increased apoptosis.
    Type: Application
    Filed: September 24, 2012
    Publication date: October 30, 2014
    Applicant: WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
    Inventors: Dominik Bettenworth, Markus Boehm, Andreas Luegering